Administration Efficacy/effectiveness Safety All age groups Influenza Pneumococcal disease
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Administration Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Economic aspects Efficacy/effectiveness Safety Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Safety Administration Adults (18+) Elderly (65+) Influenza Pneumococcal disease
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus